Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - escape treatment: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
m 1 revision imported
m 1 revision imported
 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|has_document=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|RefScope=HM
|module=2
|RefDocPart=Glossary - escape treatment
|unit=2.4.0
|RefLanguage=EN
|scope=HM
|RefTagsEN=
|doc_part=Glossary - escape treatment
|RefTagsOriginal=
|language=EN
|RefTagsFR=
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00062-Med-tre ++ TAG-00244-Def-ini ++ TAG-00277-Pla-par
|tags_display=[[Glossary:TAG-00062-Med-tre|Medical care]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00277-Pla-par|Placebo]]
|comment=Definition of escape treatment
|content=escape treatment
Any supplementary treatment provided to relieve the trial subject of symptoms caused by the investigated disease in the clinical trial. Escape treatment is often used in order to alleviate pain in placebo-controlled trials.
}}
}}
== Document Information ==
{{:Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995}}
== Reference Details ==
{| class="wikitable" style="width:100%;"
|-
! scope="row" style="width:200px;" | Scope
| HM
|-
! scope="row" style="width:200px;" | Document part
| Glossary - escape treatment
|-
! scope="row" style="width:200px;" | Language
| EN
|-
! scope="row" style="width:200px;" | Original entry by
| Florian Adragna
|-
! scope="row" style="width:200px;" | Contributors
|
|-
! scope="row" style="width:200px;" | Tags (EN)
|
|-
! scope="row" style="width:200px;" | Tags (original language)
|
|-
! scope="row" style="width:200px;" | Tags (FR)
|
|-
! scope="row" | Comment
| Definition of escape treatment
|}
== Text ==
escape treatment
Any supplementary treatment provided to relieve the trial subject of symptoms caused by the investigated disease in the clinical trial. Escape treatment is often used in order to alleviate pain in placebo-controlled trials.

Latest revision as of 13:49, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 — Unit 2.4.0
Scope HM
Document part Glossary - escape treatment
Language EN
Original entry by Florian Adragna
Contributors
Tags Medical care, Definition, Placebo

Content

escape treatment Any supplementary treatment provided to relieve the trial subject of symptoms caused by the investigated disease in the clinical trial. Escape treatment is often used in order to alleviate pain in placebo-controlled trials.

Retrieved from "https://gxplex.org/index.php?title=Reference:WHO_WHO_-_Guidelines_for_GCP_for_trials_on_pharmaceutical_products*_1995_Glossary_-_escape_treatment&oldid=18069"